Share this article on:

Target-Controlled Infusion: A Mature Technology Erratum

doi: 10.1213/ANE.0000000000002523
Errata: Errata

The article, “Target-Controlled Infusion: A Mature Technology,” which appeared in the January 2016 issue of Anesthesia & Analgesia on page 73, contained an error in the Figure 2 legend.

Incorrect Figure 2 legend: Images of open target-controlled infusion devices sold between 2004 and 2013 by the companies to whom the questionnaire was sent. A, Base Primea (Fresenius Kabi); (B) Injectomat TIVA (Fresenius Kabi); (C) Alaris PK (Carefusion); (D) Arcomed μSP 6000; (E) Arcomed μVP 7000; (F) PION TCI pump (Bionet; withdrawn from market, no longer available); (G) Infusomat Space and Perfusor Space pumps (B. Braun); and (H) Concert-CL (Veryark).

Correct Figure 2 legend: Images of open target-controlled infusion devices sold between 2004 and 2013 by the companies to whom the questionnaire was sent. (A) Base Primea (Fresenius Kabi); (B) Injectomat TIVA (Fresenius Kabi); (C) Alaris PK (Carefusion); (D) Arcomed μSP 6000; (E) Arcomed μVP 7000; (F) PION TCI pump (Bionet); (G) Infusomat Space and Perfusor Space pumps (B. Braun); and (H) Concert-CL (Veryark).

Back to Top | Article Outline

Reference

1. Absalom AR, Glen JI, Zwart GJ, Schnider TW, Struys MM. Target-controlled infusion: a mature technology. Anesth Analg. 2016;122:70–78.
    © 2017 International Anesthesia Research Society